Gain of function mutations which activate glucokinase are associated with conditions of low blood glucose such as hyperinsulinemic hypoglycemia of infancy [6], [7] whereas loss of function variants are associated with hyperglycemia and various forms of diabetes [8], [9]. Here, GCK is linked to diabetes mellitus.